Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relacorilant Food Interaction Study
NCT03442621Phase 1Completed
- Sponsor
- Corcept Therapeutics
- Start
- Jan 2018
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of relacorilant in Cushing's syndrome (3 arms), sponsored by Corcept Therapeutics. Primary endpoint: Area under plasma concentration-time curve up to the last quantifiable sample. Started Jan 2018; status: completed.
02
Drugs
relacorilant
03
Conditions
Cushing's syndrome
Beyond the preview
Go deeper on NCT03442621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03442621.